Editorial: Presence and Daily Exposure to Endocrine Disruptors: How Can Human Life Change?

Elena Grasselli, Grasselli E, Dvorakova M, Marketa Dvorakova, Graceli JB, Jones B Graceli
Frontiers in endocrinology · 2021 · vol. 12 , pp. 790853 · doi:10.3389/fendo.2021.790853 · PMID:34899615 · PMC8654277
Other OA: gold CC-BY-4.0
📄 Open PDF Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash+body, 2026-08-31 ⓘ

This editorial explores how daily human exposure to endocrine disruptors may influence and change aspects of human life.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-31 · read from full text ⓘ

This editorial explores the pervasive presence of endocrine disruptors in daily life and their potential to alter human health outcomes. The authors discuss how continuous exposure to these chemical agents may impact physiological systems and contribute to various disease states. It serves as a broad commentary on environmental factors influencing human biology rather than presenting primary experimental data. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 910 characters · extracted from pmc-nxml · 4 sections · click to expand

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Coi Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Funding Information

This research was supported by CNPq (#304724/2017-3/N° 12/2017), FAPES/CNPq (PRONEX, #24/2018). JG was awarded grants by FAPES and CNPq. This research was supported by AngelConsutling s.r.l.

Author Contributions

EG conceived the topic. MD helped to manage. JG shared his previous experience and collaborated to the editorial process. All authors contributed to the article and approved the submitted version.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

MeSH descriptors

Endocrine Disruptors Endocrine Disruptors Environmental Exposure Endocrine Disruptors Endocrine Disruptors Environmental Exposure Humans Metabolic Diseases Metabolic Diseases Metabolic Diseases Metabolic Diseases Reproduction Reproduction Reproduction Time Factors

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:33:21.214126+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC